Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up

ASEM 文献综述

Official European Association of Neuro-Oncology document (2020) on “Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up”. Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are common and often dose-limiting side effects. In patients with chemotherapy-induced peripheral neurotoxicity (CIPN), recovery is in general partial with residual deficits in most patients. In these Clinical Practice Guidelines, recommendations on diagnosis, prevention and treatment of peripheral neurotoxicity and specific aspe.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。